SCOPUS 정보 검색 플랫폼

Volumn 126, Issue 1, 2011, Pages 185-192

Defining breast cancer prognosis based on molecular phenotypes: Results from a large cohort study

(8) Dawood, Shaheenah a Hu, Rong b Homes, Michelle D b,c Collins, Laura C d Schnitt, Stuart J d Connolly, James d Colditz, Graham A e Tamimi, Rulla M b,c

a DUBAI HOSPITAL (United Arab Emirates)

b BRIGHAM AND WOMEN S HOSPITAL (United States)

c HARVARD SCHOOL OF PUBLIC HEALTH (United States)

d HARVARD MEDICAL SCHOOL (United States)

e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

Breast cancer; Molecular phenotypes; Survival

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADULT; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KERATIN-5; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE; TISSUE ARRAY ANALYSIS;

EID: 79151476372 PISSN: 01676806 EISSN: 15737217 Source Type: Journal
DOI: 10.1007/s10549-010-1113-7 Document Type: Article

Times cited : (115)

References (25)

1
- 0035845511
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
- DOI 10.1073/pnas.191367098
- T Sorlie CM Perou R Tibshirani, et al. 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 10869 10874 1:CAS:528:DC%2BD3MXntVGmsbo%3D 10.1073/pnas.191367098 11553815 (Pubitemid 32878711)
- (2001) Proceedings of the National Academy of Sciences of the United States of America , vol.98 , Issue.19 , pp. 10869-10874
- Sorlie, T.¹ Perou, C.M.² Tibshirani, R.³ Aas, T.⁴ Geisler, S.⁵ Johnsen, H.⁶ Hastie, T.⁷ Eisen, M.B.⁸ Van De Rijn, M.⁹ Jeffrey, S.S.¹⁰ Thorsen, T.¹¹ Quist, H.¹² Matese, J.C.¹³ Brown, P.O.¹⁴ Botstein, D.¹⁵ Lonning, P.E.¹⁶ Borresen-Dale, A.-L.¹⁷

2
- 0037478605
- Repeated observation of breast tumor subtypes in independent gene expression data sets
- DOI 10.1073/pnas.0932692100
- T Sorlie R Tibshirani J Parker, et al. 2001 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418 8423 10.1073/pnas.0932692100 (Pubitemid 36842560)
- (2003) Proceedings of the National Academy of Sciences of the United States of America , vol.100 , Issue.14 , pp. 8418-8423
- Sorlie, T.¹ Tibshirani, R.² Parker, J.³ Hastie, T.⁴ Marron, J.S.⁵ Nobel, A.⁶ Deng, S.⁷ Johnsen, H.⁸ Pesich, R.⁹ Geisler, S.¹⁰ Demeter, J.¹¹ Perou, C.M.¹² Lonning, P.E.¹³ Brown, P.O.¹⁴ Borresen-Dale, A.-L.¹⁵ Botstein, D.¹⁶

3
- 18244409687
- Gene expression profiling predicts clinical outcome of breast cancer
- DOI 10.1038/415530a
- H Van't Veer LJ van de Dai MJ van de Vijver, et al. 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature (Lond.) 415 530 536 10.1038/415530a (Pubitemid 34130608)
- (2002) Nature , vol.415 , Issue.6871 , pp. 530-536
- Van't Veer, L.J.¹ Dai, H.² Van De Vijver, M.J.³ He, Y.D.⁴ Hart, A.A.M.⁵ Mao, M.⁶ Peterse, H.L.⁷ Van Der Kooy, K.⁸ Marton, M.J.⁹ Witteveen, A.T.¹⁰ Schreiber, G.J.¹¹ Kerkhoven, R.M.¹² Roberts, C.¹³ Linsley, P.S.¹⁴ Bernards, R.¹⁵ Friend, S.H.¹⁶

4
- 0042838307
- Breast cancer classification and prognosis based on gene expression profiles from a population-based study
- DOI 10.1073/pnas.1732912100
- C Sotiriou SY Neo LM McShane, et al. 2003 Breast cancer classification and prognosis based on gene expression profiles from a population based study Proc Natl Acad Sci USA 100 10393 10398 1:CAS:528:DC%2BD3sXntFynsrk%3D 10.1073/pnas.1732912100 12917485 (Pubitemid 37071889)
- (2003) Proceedings of the National Academy of Sciences of the United States of America , vol.100 , Issue.18 , pp. 10393-10398
- Sotiriou, C.¹ Neo, S.-Y.² McShane, L.M.³ Korn, E.L.⁴ Long, P.M.⁵ Jazaeri, A.⁶ Martiat, P.⁷ Fox, S.B.⁸ Harris, A.L.⁹ Liu, E.T.¹⁰

5
- 33646874546
- The molecular portraits of breast tumors are conserved across microarray platforms
- DOI 10.1186/1471-2164-7-96
- Z Hu C Fan DS Oh, et al. 2006 The molecular portraits of breast tumors are conserved across microarray platforms BMC Genomics 7 96 10.1186/1471-2164-7- 96 16643655 (Pubitemid 43786485)
- (2006) BMC Genomics , vol.7 , pp. 96
- Hu, Z.¹ Fan, C.² Oh, D.S.³ Marron, J.S.⁴ He, X.⁵ Qaqish, B.F.⁶ Livasy, C.⁷ Carey, L.A.⁸ Reynolds, E.⁹ Dressler, L.¹⁰ Nobel, A.¹¹ Parker, J.¹² Ewend, M.G.¹³ Sawyer, L.R.¹⁴ Wu, J.¹⁵ Liu, Y.¹⁶ Nanda, R.¹⁷ Tretiakova, M.¹⁸ Orrico, A.R.¹⁹ Dreher, D.²⁰ more..

6
- 33745834662
- Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: Gene expression analyses across three different platforms
- DOI 10.1186/1471-2164-7-127
- T Sorlie Y Wang C Xiao, et al. 2006 Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analysises across three different platforms BMC Genomics 7 127 10.1186/1471-2164-7-127 16729877 (Pubitemid 44027496)
- (2006) BMC Genomics , vol.7 , pp. 127
- Sorlie, T.¹ Wang, Y.² Xiao, C.³ Johnsen, H.⁴ Naume, B.⁵ Samaha, R.R.⁶ Borresen-Dale, A.-L.⁷

7
- 33746910265
- Concordance among gene-expression-based predictors for breast cancer
- DOI 10.1056/NEJMoa052933
- C Fan DS Oh L Wessels, et al. 2006 Concordance among gene-expression- based predictors for breast cancer N Engl J Med 355 560 569 1:CAS:528: DC%2BD28XotVKnur4%3D 10.1056/NEJMoa052933 16899776 (Pubitemid 44200649)
- (2006) New England Journal of Medicine , vol.355 , Issue.6 , pp. 560-569
- Fan, C.¹ Oh, D.S.² Wessels, L.³ Weigelt, B.⁴ Nuyten, D.S.A.⁵ Nobel, A.B.⁶ Van't Veer, L.J.⁷ Perou, C.M.⁸

8
- 4143150688
- Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
- DOI 10.1158/1078-0432.CCR-04-0220
- TO Nielson FD Hsu K Jensen, et al. 2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast cancer Clin Cancer Res 10 5367 5374 10.1158/1078-0432.CCR-04-0220 (Pubitemid 39100473)
- (2004) Clinical Cancer Research , vol.10 , Issue.16 , pp. 5367-5374
- Nielsen, T.O.¹ Hsu, F.D.² Jensen, K.³ Cheang, M.⁴ Karaca, G.⁵ Hu, Z.⁶ Hernandez-Boussard, T.⁷ Livasy, C.⁸ Cowan, D.⁹ Dressler, L.¹⁰ Akslen, L.A.¹¹ Ragaz, J.¹² Gown, A.M.¹³ Gilks, C.B.¹⁴ Van De Rijn, M.¹⁵ Perou, C.M.¹⁶

9
- 22244449596
- High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses
- DOI 10.1002/ijc.21004
- DM Abd El-Rehim G Ball SE Pinder, et al. 2005 High-throughput protein expression analysis using tissue microarray technology of a large well-characterized series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses Int J Cancer 116 340 350 1:CAS:528:DC%2BD2MXmtl2ktb0%3D 10.1002/ijc.21004 15818618 (Pubitemid 40993329)
- (2005) International Journal of Cancer , vol.116 , Issue.3 , pp. 340-350
- Abd El-Rehim, D.M.¹ Ball, G.² Finder, S.E.³ Rakha, E.⁴ Paish, C.⁵ Robertson, J.F.R.⁶ Macmillan, D.⁷ Blamey, R.W.⁸ Ellis, I.O.⁹

10
- 2642563617
- Expression of luminal and basal cytokeratins in human breast carcinoma
- DOI 10.1002/path.1559
- DM Abd El-Rehim SE Pinder CE Paish, et al. 2004 Expression of luminal and basal cytokeratins in human breast carcinoma J Pathol 203 661 671 10.1002/path.1559 15141381 (Pubitemid 38714103)
- (2004) Journal of Pathology , vol.203 , Issue.2 , pp. 661-671
- Abd El-Rehim, D.M.¹ Pinder, S.E.² Paish, C.E.³ Bell, J.⁴ Balmey, R.W.⁵ Robertson, J.F.R.⁶ Nicholson, R.I.⁷ Ellis, I.O.⁸

11
- 0036899446
- Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome
- M van de Rijn CM Perou R Tibshirani, et al. 2002 Expression of cytokeratins17 and 5 identifies a group of breast carcinomas with poor clinical outcome Am J Pathol 161 1991 1996 12466114 (Pubitemid 35434844)
- (2002) American Journal of Pathology , vol.161 , Issue.6 , pp. 1991-1996
- Van De Rijn, M.¹ Perou, C.M.² Tibshirani, R.³ Haas, P.⁴ Kallioniemi, O.⁵ Kononen, J.⁶ Torhorst, J.⁷ Sauter, G.⁸ Zuber, M.⁹ Kochli, O.R.¹⁰ Mross, F.¹¹ Dieterich, H.¹² Seitz, R.¹³ Ross, D.¹⁴ Botstein, D.¹⁵ Brown, P.¹⁶

12
- 40949121882
- Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype
- DOI 10.1158/1078-0432.CCR-07-1658
- MCU Cheang D Voduc C Bajdik, et al. 2008 Basal-like breast defined by five biomarkers has superior prognostic value than triple-negative phenotype Clin Cancer Res 14 1368 1376 1:CAS:528:DC%2BD1cXislSrs7o%3D 10.1158/1078-0432. CCR-07-1658 18316557 (Pubitemid 351413917)
- (2008) Clinical Cancer Research , vol.14 , Issue.5 , pp. 1368-1376
- Cheang, M.C.U.¹ Voduc, D.² Bajdik, C.³ Leung, S.⁴ McKinney, S.⁵ Chia, S.K.⁶ Perou, C.M.⁷ Nielsen, T.O.⁸

13
- 33847063053
- The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
- DOI 10.1158/1078-0432.CCR-06-1109
- LA Carey EC Dees L Sawyer L Gatti DT Moore F Collichio DW Ollila CI Sartor ML Graham CM Perou 2007 The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes Clin Cancer Res 13 2329 2334 1:CAS:528:DC%2BD2sXkt1enur0%3D 10.1158/1078-0432.CCR-06-1109 17438091 (Pubitemid 46698581)
- (2007) Clinical Cancer Research , vol.13 , Issue.8 , pp. 2329-2334
- Carey, L.A.¹ Dees, E.C.² Sawyer, L.³ Gatti, L.⁴ Moore, D.T.⁵ Collichio, F.⁶ Ollila, D.W.⁷ Sartor, C.I.⁸ Graham, M.L.⁹ Perou, C.M.¹⁰

14
- 33744960226
- Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
- DOI 10.1001/jama.295.21.2492
- LA Carey CM Perou CA Livasy LG Dressler D Cowan K Conway G Karaca MA Troester CK Tse S Edmiston SL Deming J Geradts MC Cheang TO Nielsen PG Moorman HS Earp RC Millikan 2006 Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2492 2502 1:CAS:528:DC%2BD28XlsV2rtLw%3D 10.1001/jama.295.21.2492 16757721 (Pubitemid 43854964)
- (2006) Journal of the American Medical Association , vol.295 , Issue.21 , pp. 2492-2502
- Carey, L.A.¹ Perou, C.M.² Livasy, C.A.³ Dressler, L.G.⁴ Cowan, D.⁵ Conway, K.⁶ Karaca, G.⁷ Troester, M.A.⁸ Chiu, K.T.⁹ Edmiston, S.¹⁰ Deming, S.L.¹¹ Geradts, J.¹² Cheang, M.C.U.¹³ Nielsen, T.O.¹⁴ Moorman, P.G.¹⁵ Earp, H.S.¹⁶ Millikan, R.C.¹⁷

15
- 57749118336
- Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer
- RM Tamimi HJ Baer J Marotti M Galan L Galaburda Y Fu, et al. 2008 Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer Breast Cancer Res 100 218 221
- (2008) Breast Cancer Res , vol.100 , pp. 218-221
- Tamimi, R.M.¹ Baer, H.J.² Marotti, J.³ Galan, M.⁴ Galaburda, L.⁵ Fu, Y.⁶

16
- 0031668810
- Using the National Death Index to obtain underlying cause of death codes
- DOI 10.1097/00043764-199809000-00010
- N Sathiakumar E Delzell O Abdalla 1998 Using the National Death Index to obtain underlying cause of death codes J Occup Environ Med 40 808 813 1:STN:280:DyaK1cvltVOnsg%3D%3D 10.1097/00043764-199809000-00010 9777565 (Pubitemid 28436140)
- (1998) Journal of Occupational and Environmental Medicine , vol.40 , Issue.9 , pp. 808-813
- Sathiakumar, N.¹ Delzell, E.² Abdalla, O.³

17
- 84907108526
- Validity of certified causes of death in breast carcinoma patients
- 1:STN:280:DyaL28%2FpvFyrug%3D%3D 10.3109/02841868509134405 3002134
- LE Rutqvist 1985 Validity of certified causes of death in breast carcinoma patients Acta Radiol Oncol 24 385 390 1:STN:280:DyaL28%2FpvFyrug%3D%3D 10.3109/02841868509134405 3002134
- (1985) Acta Radiol Oncol , vol.24 , pp. 385-390
- Rutqvist, L.E.¹

18
- 0021321722
- Test of the National Death Index
- 1:STN:280:DyaL2c3gtVWiug%3D%3D 6720679
- MJ Stampfer WC Willett FE Speizer, et al. 1984 Test of the National Death Index Am J Epidemiol 119 837 839 1:STN:280:DyaL2c3gtVWiug%3D%3D 6720679
- (1984) Am J Epidemiol , vol.119 , pp. 837-839
- Stampfer, M.J.¹ Willett, W.C.² Speizer, F.E.³

19
- 0003516667
- 3 Lippincott Philadelphia
- Harris J, Lippman M, Morrow M, Osborne C (2004) Diseases of the breast, 3rd edn. Lippincott, Philadelphia
- (2004) Diseases of the Breast
- Harris, J.¹ Lippman, M.² Morrow, M.³ Osborne, C.⁴

20
- 0035869407
- Use of chemotherapy plus a monoclonal antibody against her2 for metastatic breast cancer that overexpresses HER2
- DOI 10.1056/NEJM200103153441101
- DJ Slamon B Leyland-Jones S Shak, et al. 2001 Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 783 792 1:CAS:528:DC%2BD3MXisVGktrc%3D 10.1056/NEJM200103153441101 11248153 (Pubitemid 32222155)
- (2001) New England Journal of Medicine , vol.344 , Issue.11 , pp. 783-792
- Slamon, D.J.¹ Leyland-Jones, B.² Shak, S.³ Fuchs, H.⁴ Paton, V.⁵ Bajamonde, A.⁶ Fleming, T.⁷ Eiermann, W.⁸ Wolter, J.⁹ Pegram, M.¹⁰ Baselga, J.¹¹ Norton, L.¹²

21
- 26844536978
- Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
- DOI 10.1056/NEJMoa052122
- EH Romond EA Perez J Bryant, et al. 2005 Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 1673 1684 1:CAS:528:DC%2BD2MXhtFansr3F 10.1056/NEJMoa052122 16236738 (Pubitemid 41464706)
- (2005) New England Journal of Medicine , vol.353 , Issue.16 , pp. 1673-1684
- Romond, E.H.¹ Perez, E.A.² Bryant, J.³ Suman, V.J.⁴ Geyer Jr., C.E.⁵ Davidson, N.E.⁶ Tan-Chiu, E.⁷ Martino, S.⁸ Paik, S.⁹ Kaufman, P.A.¹⁰ Swain, S.M.¹¹ Pisansky, T.M.¹² Fehrenbacher, L.¹³ Kutteh, L.A.¹⁴ Vogel, V.G.¹⁵ Visscher, D.W.¹⁶ Yothers, G.¹⁷ Jenkins, R.B.¹⁸ Brown, A.M.¹⁹ Dakhil, S.R.²⁰ more..

22
- 26844503270
- Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
- DOI 10.1056/NEJMoa052306
- MJ Piccart-Gebhart M Procter B Leyland-Jones, et al. 2005 Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer N Engl J Med 353 1659 1672 1:CAS:528:DC%2BD2MXhtFansr3L 10.1056/NEJMoa052306 16236737 (Pubitemid 41464705)
- (2005) New England Journal of Medicine , vol.353 , Issue.16 , pp. 1659-1672
- Piccart-Gebhart, M.J.¹ Procter, M.² Leyland-Jones, B.³ Goldhirsch, A.⁴ Untch, M.⁵ Smith, I.⁶ Gianni, L.⁷ Baselga, J.⁸ Bell, R.⁹ Jackisch, C.¹⁰ Cameron, D.¹¹ Dowsett, M.¹² Barrios, C.H.¹³ Steger, G.¹⁴ Huang, C.-S.¹⁵ Andersson, M.¹⁶ Inbar, M.¹⁷ Lichinitser, M.¹⁸ Lang, I.¹⁹ Nitz, U.²⁰ more..

23
- 33344478381
- Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer
- DOI 10.1056/NEJMoa053028
- H Joensuu PL Kellokumpu-Lehtinen P Bono, et al. 2006 Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer N Engl J Med 354 809 820 1:CAS:528:DC%2BD28Xhsl2gsrY%3D 10.1056/NEJMoa053028 16495393 (Pubitemid 43290919)
- (2006) New England Journal of Medicine , vol.354 , Issue.8 , pp. 809-820
- Joensuu, H.¹ Kellokumpu-Lehtinen, P.-L.² Bono, P.³ Alanko, T.⁴ Kataja, V.⁵ Asola, R.⁶ Utriainen, T.⁷ Kokko, R.⁸ Hemminki, A.⁹ Tarkkanen, M.¹⁰ Turpeenniemi-Hujanen, T.¹¹ Jyrkkio, S.¹² Flander, M.¹³ Helle, L.¹⁴ Ingalsuo, S.¹⁵ Johansson, K.¹⁶ Jaaskelainen, A.-S.¹⁷ Pajunen, M.¹⁸ Rauhala, M.¹⁹ Kaleva-Kerola, J.²⁰ more..

24
- 61349178197
- Prognosis of women with stage IV breast cancer by HER2 status and trastuzumab treatment: An institutional based review
- S Dawood B Kristine GN Hortobagyi SH Giordano 2008 Prognosis of women with stage IV breast cancer by HER2 status and trastuzumab treatment: An institutional based review J Clin Oncol 26 suppl 1018
- (2008) J Clin Oncol , vol.26 , Issue.SUPPL. , pp. 1018
- Dawood, S.¹ Kristine, B.² Hortobagyi, G.N.³ Giordano, S.H.⁴

25
- 19344364880
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
- DOI 10.1016/S0140-6736(05)66544-0, PII S0140673605665440
- Early Breast Cancer Trialists' Collaborative Group 2005 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials Lancet 365 1687 1717 10.1016/S0140-6736(05)66544-0 (Pubitemid 40719106)
- (2005) Lancet , vol.365 , Issue.9472 , pp. 1687-1717

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.